Lead Compound Discovery
Lead Compound Discovery is the process of identifying a biologically active natural product with desirable pharmacological properties from a natural source or extract, serving as a starting point for drug development.
996
Publications
61.4K
Citations
6.5K
Authors
1.3K
Institutions
Publications per year
2017–2026
311
996
Thousands of chemical starting points for antimalarial lead identification
Francisco‐Javier Gamo, Laura M. Sanz, Jaume Vidal et al. · Nature · 2010 · 1K citations
1–5 of 996
6.5K
7
h-index
6
h-index
British American Tobacco (United Kingdom), United Kingdom
5 publications · 321 citations
5
h-index
Universidad Central "Marta Abreu" de las Villas (UCLV), Cuba
5 publications · 202 citations
5
h-index
5
h-index
1–5 of 6.5K
1.3K

Chinese Academy of Sciences
Beijing, China
20 h-index
156 publications
4.6K citations
Shanghai Institute of Materia Medica
Pudong, China
17 h-index
84 publications
2.7K citations

GlaxoSmithKline (United Kingdom)
London, United Kingdom
16 h-index
82 publications
5.1K citations
University of Chinese Academy of Sciences
Beijing, China
16 h-index
54 publications
1.5K citations

China Pharmaceutical University
Nanjing, China
14 h-index
96 publications
2.5K citations
University of California, San Francisco
San Francisco, United States
12 h-index
52 publications
4.3K citations
Pfizer (United States)
New York, United States
12 h-index
111 publications
13.3K citations
University of Illinois Chicago
Chicago, United States
11 h-index
62 publications
4.4K citations
1–8 of 1.3K
119 publications · 7.9K citations
52
h-index
52 publications · 1.8K citations
26
h-index
30 publications · 1.2K citations
21
h-index
JCIM · 27 publications · 2.7K citations
20
h-index
30 publications · 897 citations
19
h-index
1–5